Here are the 10-Q quarterly reports from BWX Technologies, Inc. (BWXT) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow BWXT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BWXT filings page.
BWX Technologies, Inc. (BWXT) reported third-quarter 2026 revenue of $953.0 million, up 10.0% from $866.3 million, and net income attributable to BWXT of $101.7 million, versus $82.1 million. Diluted earnings per share were $1.11, compared with $0.89. For the first nine months, revenue was $2,714.8 million versus $2,312.6 million, and operating cash flow was $451.7 million versus $352.9 million.
Government Operations quarterly revenue rose 3.6% to $639.1 million; Commercial Operations revenue rose 25.2% to $314.2 million, while its operating margin was 8.4%, compared with 9.5%. BWXT completed its Precision Components Group acquisition on July 1, 2026. On July 31, it agreed to sell its medical business to Nordic Capital in a transaction valued at up to $800 million. The sale is subject to customary regulatory approvals and expected to be completed in 2026 or the first quarter of 2027; BWXT will retain a minority interest and provide specialized isotope and radiochemical expertise.
Backlog was $8,556.2 million as of September 30, 2026, including $1,970.9 million of unfunded U.S. Government contract backlog. BWXT expects approximately 46% of backlog-related revenue to be recognized by the end of 2027, with the remainder thereafter.
BWX Technologies, Inc. filed an amendment to its Q2 2026 quarterly report solely to add omitted iXBRL data; financial results remain unchanged. For the quarter ended June 30, 2026, revenue was $901,625 (in thousands), up 18.0% year over year, and net income attributable to the company was $89,014 (in thousands), or $0.97 per diluted share.
For the first six months, revenue reached $1,761,842 (in thousands) and net income was $180,084 (in thousands), driven by strong growth in Commercial Operations, where revenue rose to $586,158 (in thousands) and operating income to $48,361 (in thousands). Government Operations revenue increased to $1,179,191 (in thousands) while operating income edged slightly lower to $204,819 (in thousands) after prior-year contract catch-up benefits.
Operating cash flow was $249,003 (in thousands) for the first half, and cash and restricted cash totaled $616,273 (in thousands) with no borrowings under a $1.25 billion revolving credit facility. Backlog stood at $8,398.1 million, about 55% expected to be recognized as revenue by the end of 2027. Recent moves include the acquisitions of Aerojet Ordnance Tennessee and Kinectrics, the July 2026 purchase of Precision Components Group, and an agreement to sell the medical business to Nordic Capital for up to $800 million while retaining a minority interest.
BWX Technologies, Inc. reported higher results for the quarter and six months ended June 30, 2026. Second‑quarter revenue was $901.6 million, up from $764.0 million, and net income attributable to BWXT was $89.0 million, compared with $78.4 million. Diluted EPS was $0.97 versus $0.85.
For the first half of 2026, revenue rose to $1.76 billion and net income attributable to BWXT to $180.1 million. Commercial Operations grew sharply, with revenue of $586.2 million and operating income of $48.4 million, helped by the 2025 Kinectrics acquisition, while Government Operations revenue increased modestly and operating income was slightly lower.
Cash from operating activities increased to $249.0 million in the first half, and cash and restricted cash totaled $616.3 million at June 30, 2026 against $2.02 billion of long‑term debt. Backlog reached $8.40 billion, with about 55% expected to be recognized as revenue by the end of 2027. BWXT completed the acquisition of Precision Components Group on July 1, 2026 and agreed to sell its medical business to Nordic Capital in a transaction valued at up to $800 million, retaining a minority interest and providing ongoing isotope and radiochemical support.
BWX Technologies, Inc. reported solid growth for the quarter ended March 31, 2026, with revenues of $860.2 million, up from $682.3 million a year earlier, and net income of $91.2 million. Diluted earnings per share rose to $0.99 from $0.82.
Government Operations revenue increased to $577.9 million, while Commercial Operations more than doubled to $283.6 million, driven largely by the 2025 acquisition of Kinectrics and higher inspection, maintenance and manufacturing activity. Operating income improved to $106.7 million, with Commercial margins expanding.
Cash provided by operating activities strengthened to $92.6 million, and cash and restricted cash totaled $520.3 million against long‑term debt of about $2.0 billion. Backlog reached $8.65 billion, and the company plans to acquire Precision Components Group to further expand U.S. commercial nuclear manufacturing capacity.
BWX Technologies reported stronger Q3 results, with revenue of $866.3 million up from $672.0 million and diluted EPS of $0.89 versus $0.76 a year ago. Operating income rose to $113.3 million, supported by higher activity in both Government and Commercial Operations.
Year to date, revenue reached $2.31 billion and diluted EPS was $2.57. Operating cash flow for the nine months was a solid $352.9 million, offset by investing cash outflows of $673.9 million primarily for acquisitions. The company closed the Aerojet Ordnance Tennessee purchase for about $101.1 million and acquired Kinectrics for $441.4 million (U.S. dollar equivalent), expanding lifecycle services and isotope capabilities.
Total assets increased to $3.78 billion, with long‑term debt at $1.50 billion and total equity at $1.24 billion. Remaining performance obligations were $7,389.1 million, with about 35% expected to be recognized by the end of 2026. The quarter included favorable cumulative adjustments, and Commercial Operations growth reflects added Canadian non‑government revenue.